Sustained local drug delivery to the arterial wall via biodegradable microspheres

Catheterization and Cardiovascular Diagnosis

Volumn 41, Issue 3, 1997, Pages 324-332

  Dev, Vishva ^a   Eigler, Neal ^a   Fishbein, Michael C ^b   Tian, Youqin ^c   Hickey, Anthony ^c   Rechavia, Eldad ^a   Forrester, James S ^a   Litvack, Frank ^a,d  

^a Cardiovascular Intervention Center   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^d NONE   (United States)

Author keywords

Angioplasty; Local drug delivery; Microspheres

Indexed keywords

COLCHICINE; DEXAMETHASONE; MICROSPHERE; POLYLACTIC ACID; RHODAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTERY WALL; ARTICLE; BALLOON CATHETER; BOLUS INJECTION; CAROTID ARTERY OBSTRUCTION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; INTRAARTERIAL DRUG ADMINISTRATION; INTRACORONARY INFUSION; NONHUMAN; PARTICLE SIZE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; RABBIT; RESTENOSIS; SUSTAINED DRUG RELEASE;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANIMALS; ANTI-INFLAMMATORY AGENTS; CAROTID ARTERIES; CAROTID ARTERY INJURIES; COLCHICINE; DEXAMETHASONE; DRUG DELIVERY SYSTEMS; FIBROMUSCULAR DYSPLASIA; MICROSCOPY, FLUORESCENCE; MICROSPHERES; MUSCLE, SMOOTH, VASCULAR; RABBITS; TUNICA INTIMA; TUNICA MEDIA;

EID: 0030741178     PISSN: 00986569     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0304(199707)41:3<324::AID-CCD14>3.0.CO;2-N     Document Type: Article

References (37)

1. Holmes DR, Schwartz RS: Restenosis: The clinical problem. Coron Artery Dis 4:229-231, 1993.
2. Popma JJ, Califf RM, Topol EJ: Clinical trials of restenosis after coronary angioplasty. Circulation 84:1426-1436, 1991.
3. Forrester JS, Fishbein M, Helfant R, Fagin J: A paradigm for restenosis based on cell biology: Clues for development of new preventive therapies. J Am Coll Cardiol 17:758-769, 1991.
4. Schwartz RS, Holmes DR, Topol EJ: The restenosis paradigm revisited: An alternative proposal for cellular mechanisms. J Am Coll Cardiol 20:1284-1293, 1992.
5. Wong CS, Leon MB, Popma JJ: New device angioplasty: the impact on restenosis. Coron Artery Dis 4:243-253, 1993.
6. Herrman JR, Hermans WRM, Vos J, Serruys PW: Pharmacological approaches to the prevention of restenosis following angioplasty: Search for the holy grail? (part I). Drugs 46:18-52, 1993.
7. Franklin SM, Faxon DP: Pharmacologic prevention of restenosis after coronary angioplasty: Review of randomized clinical trials. Coron Artery Dis 4:232-242, 1993.
8. Wolinsky M, Thurg SN: Use of a perforated balloon catheter to deliver concentrated heparin into the wall of the normal canine arteries. J Am Coll Cardiol 15:475-481, 1990.
9. De Scheerder I, Vrolix M, Lierde J van, Corelis A, Piessens J: Prototype microporous balloon angioplasty: Transient drug delivery at the expense of more vessel injury [abstract No. 8]. Restenosis Summit IV:9, 1992.
10. Lambert CR, Leone J, Rowland S: The microporous balloon: A minimal-trauma local drug delivery catheter [abstract]. Circulation 86:1-381, 1992.
11. Kissel T, Brich Z, Bantle S, Lancranjan I, Nimmerfall F, Vit P: Parenteral depot systems on the basis of biodegradable polyesters. J Control Rel 16:27-42, 1991.
12. DeLuca PP, Hickey AJ, Hazrati Am, Wedlund P, Rypacek F, Kanke M: Porous biodegradable microspheres for parenteral administration. In Breimer DD, Speiser P (eds): "Topics in Pharmaceutical Sciences." New York: Elsevier Science Publishers B.V., 1987, pp 429-442.
13. Cowsar DR, Tice TR, Gilley RM, English JP: Poly(lactide-co-glycolide) microcapsules for controlled release of steroids. Methods Enzymol 12:101-115, 1985.
14. Cutbright ED, Perez B, Beasley JD, Larson WJ, Posey WR: Degradation rates of polymers and copolymers of polylactic acid and polyglycollic acid. Oral Surg 37:142-152, 1994.
15. Grandfils C, Flandroy P, Nihant N, Barbette S, Jerome R, Teyssie P, Thibaut A: Preparation of poly(DL) lactide microspheres by emulsion-solvent evaporation and their clinical application as a convenient embolic material. J Biomed Materials Res 26:467-479, 1992.
16. Visscher GE, Robinson RL, Maulding HV, Fong JW, Pearson JE, Argentieri GJ: Biodegradation of and tissue reaction to 50:50 poly (DL-lactide-co-glycolide) microcapsules. J Biomed Materials Res 19:349-365, 1985.
17. Schakenraad JM, Nieuwenhuis P, Molenaar I, Helder J, Dijkstra PJ, Feijen J: In vivo and in vitro degradation of glycollic/lactic acid copolymers. J Biomed Materials Res 23:1271-1288, 1989.
18. Martin A: "Physical Pharmacy," 4th ed. Philadelphia: Lea and Febiger, 1993, pp 423-452.
19. "The Merck Index," 11th ed. Rahway, NJ: Merck and Co., Inc., 1989, p 386.
20. "The Merck Index," 11th ed. Rahway, NJ: Merck and Co., Inc., 1989, p 463.
21. Tian Y, Parasrampuria M, Kanke M, Hickey AJ: Manufacture and in-vitro assessment of bromsulphthalein and phenolphthalein loaded polyester microspheres. Drug Dev Ind Pharm 20:1159-1178, 1994.
22. Lecrec G, Takeshita S, Nikol S, Weir L, Isner JM: Percutaneous arterial gene transfer in rabbit model. J Clin Invest 90:936-944, 1992.
23. Dev V, Lambert T, Sheth S, Eigler N, Forrester J, Litvack F: Kinetics of drug delivery to the arterial wall via polyurethane coated removable nitinol stent - Comparative study of 2 drugs [abstract]. Circulation 88:1-310, 1993.
24. Azrin MA, Mitchel JF, Pedersen C, Cartun R, Waters D, McKay RG: Local delivery of heparin on hydrogel-coated balloons decreases vessel wall cellular proliferation following balloon angioplasty [abstract]. Circulation 88:1-310, 1993.
25. Crawford N: Electropermeabilized platelets as drug delivery vehicles - Possible strategy for prevention of postangioplasty re-occlusion and restenosis. Restenosis Summit V:284-294, 1993.
26. Nilsson J: Cytokines and smooth muscle cells in atherosclerosis. Circ Res 27:1184-1190, 1993.
27. Lincoff AM, van der Giessen WJ, Schwartz RS, van Beusekom HMM, Serruys PW, Holmes DR, Ellis SG, Topol EJ: Biodegradable and biostable polymers may both cause vigorous inflammatory responses when implanted in porcine coronary arteries. J Am Coll Cardiol 21:1794, 1993.
28. Stack RS: The Duke bioabsorbable stent. Restenosis Summit V:270-276, 1993.
29. Karas SP, Gravanis MB, Santonian EC, Robinsin KA, Anderberg KA, King SP: Coronary intimal proliferation after balloon injury and stenting in swine: An animal model of restenosis. J Am Coll Cardiol 20:467-474, 1992.
30. OKeefe JH Jr, McCallister BD, Bateman TM, Kuhnlein DL, Ligon RW, Hartzler GO: Ineffectiveness of colchicine for the prevention of restenosis after coronary angioplasty. J Am Coll Cardiol 19:1597-1600, 1992.
31. Bauriedel G, Ganesh S, Uberfuhr P, Welsch U, Hofling B: Growth inhibiting effects of colchicine on cultured vascular wall myocytes from arteriosclerotic lesions. Zeitschr Kardiol 81:92-98, 1992.
32. Muller DW, Ellis SG, Topol EJ: Colchicine and antineoplastic therapy for the prevention of restenosis after percutaneous coronary interventions. J Am Coll Cardiol 17:1268-1318, 1991.
33. MacDonald RG, Panush RS, Pepine CJ: Rationale for use of glucocorticoids in modification of restenosis after percutaneous transluminal coronary angioplasty. Am J Cardiol 60:56B-60B, 1987.
34. Stone GW, Rutherford BD, McConahay DR, Johnson WL, Giorgi LV, Ligon RW, Hartzler GO: A randomized trial of corticosteroids for the prevention of restenosis in 102 patients undergoing repeat coronary angioplasty. Cathet Cardiovasc Diagn 18:227-231, 1989.
35. Pepine CJ, Hirshfeld JW, Macdonald RG, Henderson MA, Bass TA, Goldberg S, Savage MP, Vetrovec G, Cowley M, Taussig AS, Whitworth HB, Margolis JR, Hill JA, Bove AA, Jugo R: A controlled trial of corticosteroids to prevent restenosis after coronary angioplasty. Circulation 81:1753-1761, 1990.
36. Kloner RA, Fishbein MC, Lew H, Maroko PR, Braunwald E: Mummification of the infarcted myocardium by high dose corticosteroids. Circulation 57:56-63, 1978.
37. Hickey AJ, Tian Y, Parasrampuria D, Kanke M: Biliary elimination of bromsulphthalein, phenolphthalein, and doxorubicin released from microspheres following intravenous administration. Biopharm Drug Disp 14:181-186, 1993.